Pascual Marco

Universitat de Miguel Hernández d'Elx — Spain

Medicine · Health Sciences

29h-index3.9kcitations163works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(39), Blood Coagulation and Thrombosis Mechanisms(34), Hemophilia Treatment and Research(30), Atrial Fibrillation Management and Outcomes(28), Platelet Disorders and Treatments(25)

Publications162 total

Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines
International Journal of Surgery·2025Open Access
Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt
Liver International·2025Open Access
Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain
Blood·2025Open Access
Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Infectious complications in acquired haemophilia A: Insights from the Spanish Registry (AHASR)
Haematologica·2025Open Access
Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19
Scientific Reports·2025· 1 citedOpen Access
Real-World Evidence on Joint Condition in Non-Severe Hemophilia A Patients: A Multicenter Study
Journal of Blood Medicine·2025Open Access
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin
PLoS ONE·2025· 3 citedOpen Access
Machine Learning for Predicting Thrombotic Recurrence in Antiphospholipid Syndrome
2025Open Access
Health Technology Assessment of Awake Surgery Vs Traditional Surgery in Brain Tumor Resection: Clinical, Economic and Patient-Centered Perspectives
2025
Using Artificial Intelligence to Predict Joint Damage in Non-Severe Hemophilia A
SSRN Electronic Journal·2025Open Access
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study
The Oncologist·2024Open Access
Moderate haemophilia A: Recommendations from a Spanish panel of experts
Haemophilia·2024
Thrombomodulin Resistance: a Novel Prothrombotic Pathway in Covid-19
2024Open Access
Management of Thrombosis in a Patient with Three Thrombophilic Disorders
Journal of Blood Medicine·2024Open Access
Epidemiology of patients followed by the post-stroke palliative care team in a reference hospital for stroke treatment in Santa Catarina
Arquivos de Neuro-Psiquiatria·2024Open Access
Stroke palliative care protocol implementation in a reference hospital for stroke treatment in Joinville, Santa Catarina
Arquivos de Neuro-Psiquiatria·2024Open Access
Real Word Data on Levels of Emicizumab and Their Correspondence with the Global Hemostatic Capacity and the Spontaneous Joint Bleeding in Patients on Emicizumab Prophylaxis
Blood·2023
Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group
Blood·2023Open Access
PB1275 Multicenter and Cross-Sectional Study of Joint Damage of Patients with Non-Severe Hemophilia: A “Mediterranean Group” Study
Research and Practice in Thrombosis and Haemostasis·2023Open Access
page 1 of 9Next →

Frequent Co-authors

Francisco Marı́n(15), Vanessa Roldán(13), Teresa López‐Fernández(6), Ana Martín‐Garcia(6), Ramón García‐Sánz(6), Pilar Mazón‐Ramos(6), Sonia Velasco del Castillo(6), Antonio Castro Fernández(6), Cristina Mitroi(6), Meritxell Arenas(6), Javier Pineda(6), Francisco Sogorb(6), María Eva Mingot‐Castellano(6), Juan V. Llau(5), José Mateo(5), Paul Knoebl(4), F. Baudo(4), Peter W. Collins(4), Angela Huth‐Kühne(4), László Nemes(4)